BlackRock Health Sciences Trust Financial Ratios — BME Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	7.68	19.98	16.03	10.09	-4.32	3.37	4.14	13.81
Return on Assets (%)	- -	6.5	19.75	15.79	9.83	-4.22	3.33	4.09	13.74
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	99.35	98.05	99.48	99.34	99.09	101.93	98.07	97.44	99.27
Profit Margin (%)	99.35	98.05	99.48	99.34	99.09	101.93	98.07	97.44	99.27
Net Income to Common Margin (%)	99.35	98.05	99.48	99.34	99.09	101.93	98.07	97.44	99.27
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	33.08	96.27	29.1	32.24	49.06	-123.63	175.35	153.16	52.76
Sustainable Growth Rate (%)	- -	0.29	14.17	10.86	5.14	-9.66	-2.54	-2.2	6.52

Credit (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	69.29	99.21	98.55	98.45	96.45	99.02	98.66	99.23	99.68
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Net Debt to Equity	- -	- -	-0.02	-0.04	- -	- -	- -	- -	- -
Net Debt/Capital (%)	- -	- -	-0.02	-0.04	- -	- -	- -	- -	- -
EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Liquidity (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -
Current Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -
Quick Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Avg Current Liab	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	69.29	99.21	98.55	98.45	96.45	99.02	98.66	99.23	99.68
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
CFO/Total Liabilities	-42.47	72.95	-214.25	-224.59	-93.57	-14.73	401.81	1,545.25	2,977.32
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	0.18	0.46	0.65	0.67	0.6	0.36	0.43	0.46	0.65

Working Capital (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Capital	232	353	447	546	626	600	588	546	568
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.01	0.03	- -
Total Debt / EV	1.11	- -	- -	- -	- -	-14.75	1.01	1.04	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	0.01	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV per Share	- -	- -	- -	- -	- -	- -	- -	0.01	- -
TTM Sales	61	23	80	80	60	-26	20	24	78
TTM EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Cash Flow to Firm	-1	2	-14	-19	-22	-1	32	66	55
TTM Free Cash Flow to Firm	-1	2	-14	-19	-22	-1	32	66	55

Multiples (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	0.01	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	0.01	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	0.01	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	0.01	- -
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -

Shares Outstanding	9	10	11	12	13	14	14	13	13
Diluted Weighted Avg Shares	9	9	10	12	12	13	14	14	- -
Basic Weighted Avg Shares	9	9	10	12	12	13	14	14	- -
Revenue per Share	6.83	2.63	7.76	6.92	4.78	-2.06	1.47	1.67	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	6.79	2.58	7.72	6.87	4.74	-2.1	1.44	1.63	- -
Basic EPS from Cont Ops	6.79	2.58	7.72	6.87	4.74	-2.1	1.44	1.63	- -
Diluted EPS, GAAP	6.79	2.58	7.72	6.87	4.74	-2.1	1.44	1.63	- -
Diluted EPS from Cont Ops	6.79	2.58	7.72	6.87	4.74	-2.1	1.44	1.63	- -
Dividend per Share	2.25	2.48	2.25	2.21	2.33	2.6	2.52	2.5	- -
Cash Flow per Share	-0.13	0.24	-1.36	-1.67	-1.73	-0.07	2.3	4.55	- -
Free Cash Flow per Basic Share	-0.13	0.24	-1.36	-1.67	-1.73	-0.07	2.3	4.55	- -
Cash & Equivalents per Share	- -	- -	0.01	0.02	- -	- -	- -	- -	- -
Book Value per Share	26.09	40.55	43.18	47.14	50.17	47.61	42.31	37.95	- -
Tangible Book Value per Share	37.34	40.55	43.18	47.14	50.17	47.61	42.31	37.95	- -

BlackRock Health Sciences Trust

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)